These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31960580)

  • 21. Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi.
    Maheswaran H; Petrou S; MacPherson P; Choko AT; Kumwenda F; Lalloo DG; Clarke A; Corbett EL
    BMC Med; 2016 Feb; 14():34. PubMed ID: 26891969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
    Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
    Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.
    Walensky RP; Horn T; McCann NC; Freedberg KA; Paltiel AD
    Ann Intern Med; 2020 May; 172(9):583-590. PubMed ID: 32150602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact and cost-effectiveness of community-based HIV self-testing in sub-Saharan Africa: a health economic and modelling analysis.
    Cambiano V; Johnson CC; Hatzold K; Terris-Prestholt F; Maheswaran H; Thirumurthy H; Figueroa C; Cowan FM; Sibanda EL; Ncube G; Revill P; Baggaley RC; Corbett EL; Phillips A;
    J Int AIDS Soc; 2019 Mar; 22 Suppl 1(Suppl Suppl 1):e25243. PubMed ID: 30907498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-led delivery of HIV self-testing to improve HIV testing, ART initiation and broader social outcomes in rural Malawi: study protocol for a cluster-randomised trial.
    Indravudh PP; Fielding K; Kumwenda MK; Nzawa R; Chilongosi R; Desmond N; Nyirenda R; Johnson CC; Baggaley RC; Hatzold K; Terris-Prestholt F; Corbett EL
    BMC Infect Dis; 2019 Sep; 19(1):814. PubMed ID: 31533646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058.
    van de Vijver DAMC; Richter AK; Boucher CAB; Gunsenheimer-Bartmeyer B; Kollan C; Nichols BE; Spinner CD; Wasem J; Schewe K; Neumann A
    Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis.
    Cambiano V; Miners A; Lampe FC; McCormack S; Gill ON; Hart G; Fenton KA; Cairns G; Thompson M; Delpech V; Rodger AJ; Phillips AN
    Lancet HIV; 2023 Nov; 10(11):e713-e722. PubMed ID: 37923485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.
    Zhao R; Fairley CK; Cook AR; Phanuphak N; He S; Tieosapjaroen W; Chow EPF; Phillips TR; Jin Tan RK; Wei Y; Shen M; Zhuang G; Ong JJ; Zhang L
    Lancet Glob Health; 2024 Feb; 12(2):e243-e256. PubMed ID: 38245115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.
    Li J; Peng L; Gilmour S; Gu J; Ruan Y; Zou H; Hao C; Hao Y; Lau JT
    BMC Infect Dis; 2018 Nov; 18(1):600. PubMed ID: 30486800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive approach to HIV/AIDS testing and linkage to treatment among men who have sex with men in Curitiba, Brazil.
    da Cruz MM; Cota VL; Lentini N; Bingham T; Parent G; Kanso S; Rosso LRB; Almeida B; Cardoso Torres RM; Nakamura CY; Santelli ACFES
    PLoS One; 2021; 16(5):e0249877. PubMed ID: 33970929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.
    Farnham PG; Sansom SL; Hutchinson AB
    Med Decis Making; 2012; 32(3):459-69. PubMed ID: 22247422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trial.
    Jamil MS; Prestage G; Fairley CK; Grulich AE; Smith KS; Chen M; Holt M; McNulty AM; Bavinton BR; Conway DP; Wand H; Keen P; Bradley J; Kolstee J; Batrouney C; Russell D; Law M; Kaldor JM; Guy RJ
    Lancet HIV; 2017 Jun; 4(6):e241-e250. PubMed ID: 28219619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
    Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
    Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men.
    Ross EL; Cinti SK; Hutton DW
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):e61-7. PubMed ID: 26977749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Willingness to distribute free rapid home HIV test kits and to test with social or sexual network associates among men who have sex with men in the United States.
    Sharma A; Chavez PR; MacGowan RJ; McNaghten AD; Mustanski B; Gravens L; Freeman AE; Sullivan PS
    AIDS Care; 2017 Dec; 29(12):1499-1503. PubMed ID: 28393612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis.
    Neilan AM; Landovitz RJ; Le MH; Grinsztejn B; Freedberg KA; McCauley M; Wattananimitgul N; Cohen MS; Ciaranello AL; Clement ME; Reddy KP; Hyle EP; Paltiel AD; Walensky RP
    Ann Intern Med; 2022 Apr; 175(4):479-489. PubMed ID: 35099992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya.
    Roberts DA; Barnabas RV; Abuna F; Lagat H; Kinuthia J; Pintye J; Bochner AF; Forsythe S; Gomez GB; Baeten JM; John-Stewart G; Levin C
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25296. PubMed ID: 31328443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of facility-based HIV self-testing among adult outpatients in Malawi.
    Nichols BE; Offorjebe OA; Cele R; Shaba F; Balakasi K; Chivwara M; Hoffman RM; Long LC; Rosen S; Dovel K
    J Int AIDS Soc; 2020 Sep; 23(9):e25612. PubMed ID: 32909387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linkages to HIV confirmatory testing and antiretroviral therapy after online, supervised, HIV self-testing among Thai men who have sex with men and transgender women.
    Phanuphak N; Jantarapakde J; Himmad L; Sungsing T; Meksena R; Phomthong S; Phoseeta P; Tongmuang S; Mingkwanrungruang P; Meekrua D; Sukthongsa S; Hongwiangchan S; Upanun N; Jirajariyavej S; Jadwattanakul T; Barisri S; Pankam T; Phanuphak P
    J Int AIDS Soc; 2020 Jan; 23(1):e25448. PubMed ID: 31960589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.